Turning loss into purpose
By K.E.D. Coan.
When Isha Antani lost both parents to COVID within 15 days, her mission became clear: fight for breakthrough therapies that offer patients a second chance. At Novartis, she is relentless in her pursuit of life-saving innovations—so that others don’t have to endure the same heartbreak she did.
Turning loss into purpose
By K.E.D. Coan.
When Isha Antani lost both parents to COVID within 15 days, her mission became clear: fight for breakthrough therapies that offer patients a second chance. At Novartis, she is relentless in her pursuit of life-saving innovations—so that others don’t have to endure the same heartbreak she did.
Turning loss into purpose
By K.E.D. Coan.
When Isha Antani lost both parents to COVID within 15 days, her mission became clear: fight for breakthrough therapies that offer patients a second chance. At Novartis, she is relentless in her pursuit of life-saving innovations—so that others don’t have to endure the same heartbreak she did.
